Market Research Logo

Neurotech Industry 2016-2017 Report

Neurotech Industry 2016-2017 Report

More than 500 profiles of public and private neurotech companies including drugs, devices and diagnostics

Pipelines and market analysis for 20 brain and nervous system illnesses including: addiction, Alzheimer's disease, anxiety, attention disorders, depression, epilepsy, hearing loss, insomnia, mild cognitive impairment, migraine, multiple sclerosis, obesity, pain, Parkinson's disease, retinal disorders, schizophrenia, stroke, and traumatic brain injury

Top neurotech investors, venture capital firms, and venture capital trends

Neurotech IPOs, M&A, Partnering and Licensing deals and public neurotech stock performance

Analysis of biological basis, current treatment options, and emerging therapeutic strategies

Analysis of compounds, cell therapies and devices in clinical trials (and abandoned) by company, mechanism of action and stage of development for each indication

Global and US market size, worldwide revenues for each indication

Extensive discussion of specific technological, demographic, regulatory and intellectual property trends

Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System:  Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness Markets.

Now in its 12th year, The Neurotechnology Industry 2016-2017 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide a comprehensive pipeline and market analysis to help investors, companies and entrepreneurs easily identify opportunities, understand the competitive landscape, determine risks and understand the dynamics of rapidly changing CNS markets.

The report includes detailed information on products in development globally for over 20 indications at 800 companies including Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, traumatic brain injury and stroke.


1: Executive Summary
The Brain Industry Revealed       
    Neuropharmaceuticals  
    Cell Therapies    
    Neurodevices       
    Neurodiagnostics        
Investment Risks and Opportunities
    Translating Neuroscience into Neurotech       
    The Neurotech Market Opportunity        
Key Industry Facts and Findings             
2: Trends and Drivers
 
Converging Technology Drivers           
    Crossing the Blood Brain Barrier      
Demographic Drivers       
    More People Living Longer      
Social Drivers      
    The Lifestyle Improvement Market              
Economic Drivers       
    Global Economic Burden of Brain-Related Illness       
    Rising Health Care Costs       
Research Funding        
    US Government Research Funding        
    Stem Cell Funding       
    International Government Research Funding       
    Foundations Focus on the Brain        
Intellectual Property Trends      
    Global Intellectual Property Protection       
    Patent Expirations       
Neurotech Merger and Acquisition Activity (2005-Q2,2016)  
3: Neuropharmaceutical Sector
 
Neuropharmaceutical Sector Overview      
    Trends in Neuropharmaceuticals       
Neuropharmaceutical Partnering and Licensing
      Partnering and Licensing Personnel
      Partnering and Licensing Deals 2004-Q2,2016
        
Neurology Markets and Pipelines        
    Alzheimer’s Disease (AD)       
    AAMI and MCI      
    ALS
    Epilepsy and Seizure Disorders   
    Huntington's disease    
    Migraine       
    Multiple Sclerosis       
    Parkinson’s Disease       
    Sleep Disorders       
         Restless Legs Syndrome       
    Stroke       
    Traumatic Brain Injury
Psychiatry Markets and Pipelines       
    Addiction       
    Anxiety Disorders       
    Attention Disorders       
    Depressive Disorders       
         Bipolar Disorder        
    Obesity       
    Schizophrenia       
         Cognitive Impairment Associated with Schizophrenia       
Sensory Markets and Pipelines       
    Pain       
    Retinal Disorders
       
4: Stem Cells and Neuroregeneration
 
Defining Stem Cell Markets and Players       
    Therapeutics       
    Drug Discovery Tools       
    Stem Cell Banking       
Stem Cell Approaches       
    Background       
    The Science of Transplantion       
    Controlling Immune Rejection and Infection       
    Sources and Harvesting of Stem Cells        
        Embronic Stem Cells      
        Fetal Stem Cells       
        Adult Stem Cells      
        Stimulation of Endogenous Stem Cells       
    Stem Cells Scientific Hurdles      
Markets and Treatments in Development       
    Alzheimer’s Disease        
    Amyotrophic Lateral Sclerosis (ALS)      
    Hearing Loss      
    Huntington’s Disease (HD)    
    Multiple Sclerosis (MS)      
    Parkinson’s Disease      
    Retinal Disorders       
    Spinal Cord Injury (SCI)      
    Stroke       
    Other CNS Diseases   
 
5: Neurodevice Sector
 
Neurodevice Sector Overview        
    Neurodevice Markets       
    Regulatory Process in the US
    Regulatory Process in the EU      
    Neurodevice Sector Trends        
    Investment by Major Device companies
    Neurodevice M&A Activity (2005-Q2, 2016)
Neuroprosthetic Devices       
    Cochlear Implants        
    Retinal Implants        
    Motor Prostheses and Brain Computer Interfaces      
Neuromodulation Devices        
    Neuromodulation Device Clinial Trials and Recent Approvals        
    Deep Brain Stimulation       
         Essential Tremor        
         Parkinson’s Disease        
         Primary Dystonia        
         Severe Obsessive Compulsive Disorder        
         Treatment-Resistant Depression        
         Epilepsy        
         Traumatic Brain Injury and Stroke        
    Transcranial Magnetic Stimulation (TMS)        
         Alzheimer's 
         Treatment Resistant Depression       
         Migraine    
    Transcranial Electrical Stimulation (TES)      
         Transcranial Direct Current Stimulation (tDCS)
         Transcranial Alternating Current Stimulation (tACS)       
         Transcranial Random Noise Stimulation (tRNS)
    Focused Ultrasonic Modulation   
    Spinal Cord Stimulation (SCS)       
         Chronic and Neuropathic Pain        
         Spinal Cord Injury        
    Vagus Nerve Stimulation (VNS)        
         Epilepsy       
         Treatment-Resistant Depression        
         Obesity        
    Peripheral Stimulation        
         Assisted Breathing
         Epilepsy       
         Fecal Incontinence        
         Foot Drop        
         Hypertension        
         Migraine        
         Neuropathic Pain        
         Restless Legs Syndrome        
         Sleep Apnea        
         Stroke        
         Urinary Conditions        
    Gastric Modulation and Obesity       
Neurosurgical devices        
    Radiosurgical Devices        
    Neurosurgical Navigation and Equipment        
         Image Guided Navigation (IGN)       
         Intraoperative Magnetic Resonance Imaging (iMRI)       
         Automated Surgical Systems        
         Brain Monitoring        
         Temperature Control Systems        
    Neurovascular Intervention         
         Ischemic Stroke        
             Catheters, Stents and Perfusion devices
             Retrieval and Protection devices
             Ultrasound Thrombolysis
         Hemorrhagic Stroke   
              Coils
              Liquid Embolics
              Stents
Neurosoftware       
    Attention Deficit Disorder       
    Cognition and Aging       
    Stress and Emotional Wellbeing       
    Autism        
    Addiction and Obesity
    Pain  
    Schizophrenia       
Therapeutic NeuroGaming
 
6: Neurodiagnostics Sector
 
Neurodiagnostic Sector Overview       
    FDA Approval and Reimbursement of Diagnostics              
Neuroimaging Technologies       
    Computed Tomography (CT)       
    Magnetic Resonance Imaging (MRI)       
    Nuclear Medicine Imaging (PET, SPECT)       
    Electro-encephalography (EEG)       
    Magneto-encephalography (MEG)       
In Vitro Diagnostics       
    In Vitro Diagnostics Regulatory Landscape       
    Emerging Diagnostics for Alzheimer’s Disease 
    Emerging Diagnostics for TBI       
    Genetic Testing and Pharmacogenomics      
    Protein Biomarker Assays       
    Pattern Recognition in Diagnostics       
    Emerging Diagnostics for Psychiatry  
    Emerging Diagnostics for Autism            
Neuroinformatics       
    Diagnostic Software        
7: Private Neurotechnology Investment
 
Private Investment in Neurotechnology       
    Venture Capital Investment Trends       
    Neurotech Venture Capital Investment       
         Investing in Neuropharmaceuticals       
         Investing in Stem Cells and Neuroregeneration      
         Investing in Neurodevices       
         Investing in Neurodiagnostics       
         Private Company Financings, 2015
         Top financings 2004-2015
         Leading Neurotech Investors
         Leading Venture Capital Firms       
8: Public Neurotechnology Investment
Investing in Public Neurotech Companies       
    Neurotech Stock Universe       
Neurotech Initial Public Offerings       
NeuroInsights Neurotech Index       
9: Neurotechnology Research Centers
 
Leading Neurotechnology Research Centers       
    University of California, San Francisco (UCSF)       
    University of California, Los Angeles (UCLA)       
    University of California, San Diego (UCSD)       
    Harvard       
    Stanford University       
    Massachusetts Institute of Technology (MIT)       
    Columbia University       
    Washington University, St. Louis       
    University College London (UCL)       
    Karolinska Institutet, Stockholm       
    RIKEN Brain Science Institute, Japan       
Places to Watch       
    National Brain Research Centre (NBRC), India       
    Neurosciences Victoria, Australia (NSV)       
    Univeristy of Helsinki, Finland
     
10: Leading Neurotechnology Regions
The Global Neurotech Economy       
Nexus Ranking and Methodology       
Established Neurotech Nexus 
Emerging Neurotech Nexus   
Nascent Neurotech Nexus 
Conclusions and Policy Recommendations       
11: Company Profiles
 
Neuropharmaceutical & Cell Therapy Companies: Private       
Neuropharmaceutical & Cell Therapy Companies: Public      
Neurodevice Companies: Private       
Neurodevice Companies: Public       
Neurodiagnostic Companies: Private       
Neurodiagnostic Companies: Public     
 
12: Index

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report